Hansa Biopharma reports robust Q4 with SEK 50m revenue By Investing.com
From Investing.com: Hansa Biopharma expects to report SEK 50 million in Q4 2023 revenue, driven by SEK 43 million from
From Investing.com: Hansa Biopharma expects to report SEK 50 million in Q4 2023 revenue, driven by SEK 43 million from
From Nasdaq: STMicroelectronics (STM) experienced mixed results in the latest market close, with a -0.65% movement compared to the previous
From Nasdaq: The Nasdaq Composite gained 43% in 2023 and investor confidence in its continued rally is growing. Expectations about
From Nasdaq: 1. 2023 saw Nasdaq Composite jump 43% as macroeconomic challenges eased. Historical data shows an average surge of
From Nasdaq: In this podcast, Motley Fool host Dylan Lewis and analysts Ron Gross and Matt Argersinger discuss 2024 trends,
From Nasdaq: The Motley Fool’s final mailbag of 2023 is available in podcast form via their podcast center. To learn
From Nasdaq: Tesla (NASDAQ: TSLA) had a record year in 2023 for electric vehicle (EV) production and deliveries. However, its
From Nasdaq: Artificial intelligence (AI) stocks are plentiful in the market, with several companies offering deeply integrated AI solutions. Super
From NASDAQ: If you’re looking to build real wealth for retirement, Prologis and Equinix are leaders to consider. Both are
From Nasdaq: Nvidia had an incredible 2023, with the stock rising nearly 240%. Its GPUs saw a surge in demand
From Investing.com: The first launch of ULA’s Vulcan rocket will take place next week at Cape Canaveral, where it will
From NASDAQ: BJ’s Restaurants (BJRI) stock price closed at $32.45, representing a -0.22% change. The stock trailed the S&P 500,
From Nasdaq: Alibaba stocks are performing poorly and are near a record low, in stark contrast to Amazon’s continued success.
From Nasdaq, Inc.: Berkshire Hathaway’s most lucrative investment thus far has been in Apple (NASDAQ: AAPL). Since it first bought
From Nasdaq: Looking to boost your portfolio this year? Innovative stocks can lead the way. CRISPR Therapeutics is a game
From Nasdaq: Long-term investing is the way to go, as it makes big goals achievable. Doubling a $3,000 investment by
From Nasdaq: Generative AI emerges as a revolutionary concept in tech, allowing AI systems to create original content. Microsoft has
From Nasdaq: Vuzix Corporation will showcase AI-powered smart glasses at CES 2024 in Las Vegas. The exhibit will include Vuzix
From Investing.com: Alaska Airlines is grounding its fleet of 65 Boeing 737 MAX 9 aircraft after a cabin panel blowout
From Nasdaq: Construction Partners, ROAD, saw an increase in stock movement lagging the S&P 500, the Dow, and Nasdaq. Their
From Nasdaq.: Alphabet GOOGL plans to introduce new features to Google Bard in 2024, including custom bots, tasks, and a
From Nasdaq: Tech stocks, including XLK and XSD, were declining premarket. Take-Two Interactive Software, TTWO, was slightly lower after offering
From Nasdaq: U.S. stock index futures signal a losing week, with the S&P 500 and Nasdaq on track for their
From Nasdaq: Alphabet’s Google has added a “Calls” tab to its Google Meet web app, integrating the meeting side with
From Nasdaq: Microsoft and the rest of the Magnificent Seven have had a slow start to 2024. Apple is currently